Not approved (research only)Research blendGrowth hormone research
CJC-1295 (no DAC) + ipamorelin
A vendor blend of CJC-1295 without DAC and ipamorelin; the combination has not been studied as a product.
What is CJC-1295 (no DAC) + ipamorelin?
A vendor blend of CJC-1295 without DAC and ipamorelin; the combination has not been studied as a product. CJC-1295 (no DAC) + ipamorelin is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Key takeaways
- CJC-1295 (no DAC) + ipamorelin is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
- PubMed indexes 51 papers on CJC-1295 (no DAC) + ipamorelin (2 tagged as clinical trials) as of October 19, 2026.
- No vendor in our directory listed CJC-1295 (no DAC) + ipamorelin when we checked.
What is in this blend?
The blend combines 2 compounds. No published study has tested this combination as a product; each component's evidence is separate.
Regulatory & access status
CJC-1295 (no DAC) + ipamorelin is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on CJC-1295 (no DAC) + ipamorelin?
PubMed indexes 51 papers mentioning CJC-1295 (no DAC) + ipamorelin in the title or abstract, 12 of them from the last five years and 2 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. — Am J Sports Med, 2026 · review
- Ipamorelin, the first selective growth hormone secretagogue. — Eur J Endocrinol, 1998
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. — J Am Acad Orthop Surg Glob Res Rev, 2026 · review
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. — Sports Med, 2026 · review
- Peptide Supplements and Their Therapeutic Applications in Sports Medicine. — Am J Sports Med, 2026
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives. — Int J Mol Sci, 2026 · review
What the evidence does not show
- Paper counts measure research attention, not whether CJC-1295 (no DAC) + ipamorelin works or is safe.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
- No study of this specific blend as sold.
Research suppliers that list CJC-1295 (no DAC) + ipamorelin
None of the vendors in our directory listed CJC-1295 (no DAC) + ipamorelin in their public catalog when we checked. The vendor directory records what each vendor publishes about testing.
CJC-1295 (no DAC) + ipamorelin reconstitution math
Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.
CJC-1295 (no DAC) + ipamorelin FAQ
Is CJC-1295 (no DAC) + ipamorelin FDA-approved?
CJC-1295 (no DAC) + ipamorelin is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Is CJC-1295 (no DAC) + ipamorelin safe?
Safety data come from the published studies listed on this page; read them in full. Products sold as "research use only" have no FDA review of their purity, sterility or dose.
How much research is there on CJC-1295 (no DAC) + ipamorelin?
PubMed indexes 51 papers on CJC-1295 (no DAC) + ipamorelin (2 tagged as clinical trials) as of October 19, 2026.
Who sells CJC-1295 (no DAC) + ipamorelin?
None of the vendors in our directory listed it when we checked.
Related compounds
Follistatin-315FollistatinGHRHGHRP-6SomatropinHexarelinBPC-157 + TB-500 blendTri-heal blendAll growth hormone & ghrhAll blends & stacks